Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Johns Hopkins Genomics, |
RCV001543694 | SCV001762392 | uncertain significance | Primary ciliary dyskinesia 3 | 2021-06-09 | criteria provided, single submitter | clinical testing | DNAH5 c.1114A>G (rs140227610) has been identified in a large population dataset and the minor allele frequency is neither low enough to consider the variant rare (<0.1%) nor high enough to consider it a population polymorphism (>1%) within the African/African-American subpopulation (gnomAD: 34/24834 alleles; 0.14%, no homozygotes). This variant has not been reported in ClinVar nor the literature to our knowledge. Three bioinformatic tools queried predict that this substitution would be tolerated and the threonine residue at this position is evolutionarily conserved across most mammalian species assessed. We consider the clinical significance of c.1114A>G to be uncertain at this time. |
Invitae | RCV002071964 | SCV002397071 | likely benign | Primary ciliary dyskinesia | 2024-01-03 | criteria provided, single submitter | clinical testing | |
UNC Molecular Genetics Laboratory, |
RCV002071964 | SCV002573556 | uncertain significance | Primary ciliary dyskinesia | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002071964 | SCV002746584 | likely benign | Primary ciliary dyskinesia | 2022-05-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |